Dr. Paul S. Fishman

Dr. Argye Hillis is a professor of Neurology, with joint faculty appointments in Physical Medicine and Rehabilitation and in Cognitive Science. She is also the Sheikh Khalifa Stroke Institute Professor of Acute Stroke Diagnoses and Management. Prior to medical training and neurology residency, Dr. Hillis worked as a speech-language pathologist, and conducted clinical research focusing on understanding and treating aphasia and hemispatial neglect. She has brought these areas of experience to impact on her clinical research in neurology, which involves cognitive and neuroimaging studies of aphasia and hemispatial neglect due to acute stroke and focal dementias. She has published extensively on these topics in journals and textbooks. Dr. Hillis is Associate Editor of Stroke and has served as Associate editor of Brain, Annals of Neurology, Aphasiology, American Journal of Speech-Language Pathology, Neurocase, Cognitive Neuropsychology, and Language and Cognitive Processes and served as co-Editor and Chief of Behavioral Neurology. Dr. Hillis serves as the Executive Vice Chair of the Department of Neurology and the Director of the Cerebrovascular Division of Neurology at Johns Hopkins. Dr. Hillis is rated as an Elite provider by MediFind in the treatment of Dementia. Her top areas of expertise are Primary Progressive Aphasia, Stroke, Frontotemporal Dementia, Thrombectomy, and Gastrostomy.

Raymond Turner is a Neurologist in Washington, Washington, D.c.. Dr. Turner is rated as an Advanced provider by MediFind in the treatment of Dementia. His top areas of expertise are Alzheimer's Disease, Dementia, Developmental Dysphasia Familial, and Memory Loss.

Dr. Scholz is a neurologist and geneticist specializing in neurodegenerative disorders such as Parkinson's disease, atypical parkinsonism and dementia syndromes. She received her medical degree from the Medical University Innsbruck, Austria. Following graduation, she was a postdoctoral fellow at the National Institutes of Health under the supervision of Drs. Andrew Singleton and John Hardy. She obtained a Ph.D. in neurogenomics from the University College London, UK in 2010. She then moved to Baltimore to complete her neurology residency training at Johns Hopkins. In 2015 Dr. Scholz received the McFarland Transition to Independence Award for Neurologist-Scientists. She is Lasker Clinical Research Scholar at the National Institute of Neurological Disorders and Stroke focusing on genetic causes of neurodegenerative syndromes, and an adjunct faculty member at Johns Hopkins' department of neurology. Dr. Scholz is rated as an Elite provider by MediFind in the treatment of Dementia. Her top areas of expertise are Lewy Body Dementia (LBD), Multiple System Atrophy, Movement Disorders, and Parkinson's Disease.